Literature DB >> 16959617

Clinicopathologic characteristics of Rosai-Dorfman disease in a medical center in northern taiwan.

Cheng-Hsiang Hsiao1, Tsen-Fang Tsai, Ting-Hua Yang, Chia-Ming Liu.   

Abstract

BACKGROUND/
PURPOSE: Rosai-Dorfman disease (RDD) is a rare histiocytic proliferative disorder that usually presents as cervical lymphadenopathy. Extranodal involvement occurs in up to 40% of patients. The disease is most prevalent in blacks and rare in Asians. This study analyzed the characteristics of RDD in patients from Taiwan.
METHODS: Fourteen patients with a diagnosis of RDD were identified by review of records from 1995 to 2004 at National Taiwan University Hospital. Tissue sections from each patient were reviewed and immunohistochemical staining was performed. Data on clinical presentations, associated diseases, treatment and outcome were analyzed. In situ hybridization for Epstein-Barr virus (EBV)-encoded small RNAs (EBER-1) was also performed. Sets of primers specific for the conservative region of bacterial 16S-rDNA, IS6110 of Mycobacterium tuberculosis complex and consensus region of human herpes virus (HHV) DNA polymerase genome were used to detect the presence of these infectious agents in the specimens.
RESULTS: There were six men and eight women with a mean age of onset of 44 years. Nine patients presented with skin lesions, four with lymph node involvement and one with nasal tumor. All lesions followed a chronic and indolent course. Most of the lesions regressed spontaneously, and no patients died as a result of this disease during follow-up. Three patients had associated immune-mediated disease, i.e. hemolytic anemia, ankylosing spondylitis and asthma. Two patients had a history of tuberculosis. Histologically, all lesions were characterized by a mixed infiltrate of large pale histiocytes, abundant plasma cells and lymphocytes regardless of the site of involvement. The strong immunoreactivities of these histiocytes to S-100 protein, CD68 and CD14 with occasional lymphophagocytosis were helpful in confirming the diagnosis, polymerase chain reaction analysis of 16S-rDNA, IS6110 and HHV gene and in situ hybridization for EBV were all negative.
CONCLUSION: RDD in Taiwan is characterized by older age of onset compared to Western countries (44 years vs. 20 years) and more frequent extranodal involvement. The skin was the most common site of extranodal involvement, with about two-thirds of patients presenting with cutaneous lesions. There was no evidence of bacterial, mycobacterial or HHV infection in this series.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959617     DOI: 10.1016/S0929-6646(09)60197-2

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  6 in total

1.  Chronic ankle pain and swelling in a 25-year-old woman: an unusual case.

Authors:  Richard W Kang; Kevin C McGill; Johnny Lin; Steven Gitelis
Journal:  Clin Orthop Relat Res       Date:  2011-03-15       Impact factor: 4.176

2.  Mesenteric histiocytosis or only an inflammatory infiltration of histiocytes? A case report from a surgical point of view.

Authors:  Florian Höhler; Karl-Heinz Dietl; Karel Novak; Joachim Giedl; Christian Paetzel
Journal:  Int Surg       Date:  2012 Jul-Sep

3.  Extranodal sinonasal Rosai-Dorfman disease: a clinical study of 10 cases.

Authors:  Hong-Gang Duan; Chun-Quan Zheng; De-Hui Wang; Guo-Qiang Ding; Ji-Qin Luo; Chao-Ping Zang; Chang Yu
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-16       Impact factor: 2.503

Review 4.  Hematolymphoid Lesions of the Sinonasal Tract.

Authors:  Friederike H Kreisel
Journal:  Head Neck Pathol       Date:  2016-02-01

5.  Rosai-Dorfman Disease with nodal and extranodal involvements: A case report.

Authors:  Mehri Najafi-Sani; Hossein Saneian; Fatemeh Mahjoub
Journal:  J Res Med Sci       Date:  2011-09       Impact factor: 1.852

6.  Rosai-Dorfman disease with lung involvement in a 10-year-old patient: A case report.

Authors:  Guo-Jing Wu; Bo-Bo Li; Ren-Liang Zhu; Chao-Jie Yang; Wen-Yong Chen
Journal:  World J Clin Cases       Date:  2021-06-16       Impact factor: 1.337

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.